Real-world use of chemotherapy for Kaposi’s sarcoma in a large communitybased HIV primary care system in Kenya

Kaposi’s sarcoma (KS) is one of the most common HIV-associated malignancies in sub-Saharan Africa. Worldwide, the availability of antiretroviral therapy (ART) has improved KS survival.